Calidi Biotherapeutics raises funds from 2 Korean firms

US based Calidi Biotherapeutics, Inc., a clinical‐stage immuno-oncology company at the forefront of cell-bas...

January 22, 2020 | Wednesday | News
KT, Samsung Medical Center create 5G-powered smart hospitals

KT Corporation, Korea's largest telecommunications company, and the Samsung Medical Center (SMC) announced last week tha...

January 21, 2020 | Tuesday | News
Bridge Biotherapeutics gets FDA IND clearance for lung cancer drug

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, Republic of Korea, announced th...

January 20, 2020 | Monday | News
Hanmi Pharma to develop innovative drugs for rare diseases

The company, led by President and CEO Se-chang Kwon and co-representative Jong-soo Woo, participated in the 38th J.P. Mo...

January 16, 2020 | Thursday | News
Korea creates smart LED contact lens to diagnose diabetes

Diabetic patients need to measure their blood-sugar level by drawing blood before and after a meal and it is easy to dev...

January 17, 2020 | Friday | News
A2A, Daewoong to co-develop novel oncology treatments

A2A Pharmaceuticals Inc. (A2A) announced an agreement to design and co-develop oncology drug candidates with Daewoong Ph...

January 16, 2020 | Thursday | News
Genome & Company inks clinical trial collaboration

Genome & Company, a clinical-stage biotechnology company based in Seongnam, Republic of Korea, has announced th...

January 15, 2020 | Wednesday | News
Macrogen inks license and supply agreement with Thermo Fisher

Kap-Seok Yang, CEO of Macrogen has announced that the company has signed a strategic License and Supply Agreem...

January 14, 2020 | Tuesday | News
Daewoong Pharma achieves significant milestone

Daewoong Infion Co. has achieved world's first halal certification for animal cells-derived biopharmaceuticals. South K...

January 8, 2020 | Wednesday | News
Mundipharma, Biosolution to market CartiLife in South Korea

Mundipharma has announced that it has sealed an exclusive sales agreement with Bio solution Co., Ltd, a Korea-based lead...

January 7, 2020 | Tuesday | News
Nunaps raises $4.2M to develop digital platform for brain damage

Nunaps, a South Korean digital therapeutics startup, has closed a KRW 5 billion (US$ 4.2 million) Series A rou...

January 6, 2020 | Monday | News
Hana Pharm submits NDA for anesthetic agent

Germany headquartered pharmaceutical company PAION AG has announced that its South Korean remimazolam licensee Hana Phar...

December 31, 2019 | Tuesday | News
Bridge Biotherapeutics announces CNMPA clearance of IND for BBT-401

Bridge Biotherapeutics Inc. a clinical stage biotech company headquartered in Seongnam, Republic of Korea has annou...

December 30, 2019 | Monday | News
GenScript, Selecxine partner for novel antibody drug development

The CDMO segment of the world's leading biotech company GenScript has announced that it has signed a strategic collabora...

December 27, 2019 | Friday | News
Bridge Biotherapeutics files Investigational NDA for NSCLC drug

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, announce...

December 20, 2019 | Friday | News
Alteogen inks license agreement for Hybrozyme Technology

Korea based Alteogen Inc. has announced that it has entered into a non-exclusive global license agreement with a to...

December 19, 2019 | Thursday | News
Nicox signs agreement for ZERVIATE in South Korea

French firm Nicox SA, an international ophthalmology company, has announced the signature of an exclusive license agreem...

December 17, 2019 | Tuesday | News
TriNetX expands into South Korea in partnership with EvidNet

US based TriNetX, the global health research network that revolutionizes clinical research and enables discoveries throu...

December 16, 2019 | Monday | News